Your session is about to expire
← Back to Search
Mobile App
CMAP App for Pressure Sore Prevention
N/A
Recruiting
Led By Christine M. Olney, BSN MS PhD
Research Sponsored by VA Office of Research and Development
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
For Aim 2: Veteran adults aged 18-80, male and female, with a recent spinal cord injury (C4 and below) or a spinal cord disorder with impaired sensory function, who are currently in inpatient rehabilitation with at least 1 week prior to discharge. Participants must demonstrate ability to access the CMAP system application on a mobile phone or tablet independently.
For Aim 1a: Veteran adults aged 18-80, male and female, with a spinal cord injury (C4 and below) or spinal cord disorder with impaired sensory function and a wheelchair user for at least one year
Must not have
For Aim 1a: Any Veteran with SCI/D who is unable to verbally and cognitively communicate with the study team
Timeline
Screening 3 weeks
Treatment Varies
Follow Up year 1-2: change from baseline to second and third focus group
Awards & highlights
No Placebo-Only Group
Summary
This trial will test whether using a pressure-mapping device on a mobile platform will help Veterans with spinal cord injury and pressure injuries related to sitting in a wheelchair.
Who is the study for?
This trial is for Veterans aged 18-80 with spinal cord injuries or disorders, who use a wheelchair and have impaired sensory function. They must be able to independently access the CMAP app on a mobile device. Excluded are those with active pressure injuries that contact their seating system, recent flap surgery, cognitive communication issues, or using customized immersion style seat cushions.
What is being tested?
The study tests if using the CMAP app for education in hospitals and at home can help prevent pressure injuries in Veterans with spinal cord injury. The app provides visual feedback on pressure distribution to encourage regular movement and weight shifting while sitting.
What are the potential side effects?
Since this intervention involves educational software rather than medication, traditional side effects are not applicable. However, participants may experience frustration or difficulty if they find the technology challenging to use.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am a veteran aged 18-80 with a recent spinal cord injury or disorder, can use a mobile app, and am in rehab.
Select...
I am a veteran aged 18-80 with a spinal cord injury (C4 or lower) or disorder, use a wheelchair, and have had impaired sensory function for over a year.
Exclusion Criteria
You may be eligible for the trial if you check “No” for criteria below:Select...
I am a Veteran with spinal cord injury/disease and cannot communicate verbally or cognitively.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ year 1-2: change from baseline to second and third focus group
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~year 1-2: change from baseline to second and third focus group
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Change in Usability as measured by System Usability Scale (SUS)
Change in Usability as measured by User Experience Questionaire (UEQ)
Usability as measured by User Experience Questionaire (UEQ)
Secondary study objectives
Change in Self-Efficacy as measured by Skin Care Belief Scale
Change in Self-Efficacy as measured by customized scale
Weight Shift bout comparisons
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
4Treatment groups
Experimental Treatment
Active Control
Group I: Usability-inpatientsExperimental Treatment1 Intervention
Clinicians will use the updated CMAP system during patient education for prevention of pressure injuries with Veterans with SCI who are completing their initial rehabilitation.
Group II: Usability-in-homeExperimental Treatment1 Intervention
The Veteran will use the CMAP system at home for two weeks to use in their daily routines, along with wearing the acti-graph one week prior, two weeks during and one week after CMAP usage.
Group III: Focus group-CliniciansActive Control1 Intervention
Clinicians will inform study staff regarding desired app design changes
Group IV: Focus group-VeteranActive Control1 Intervention
Veterans will inform study staff regarding desired device design refinements
Find a Location
Who is running the clinical trial?
VA Office of Research and DevelopmentLead Sponsor
1,664 Previous Clinical Trials
3,765,679 Total Patients Enrolled
Christine M. Olney, BSN MS PhDPrincipal InvestigatorMinneapolis VA Health Care System, Minneapolis, MN
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I am a veteran aged 18-80, use a wheelchair, and have had a spinal injury or disorder for over a year.I am a Veteran with spinal cord injury/disease and cannot communicate verbally or cognitively.I am a veteran aged 18-80 with a recent spinal cord injury or disorder, can use a mobile app, and am in rehab.I am a veteran aged 18-80 with a spinal cord injury (C4 or lower) or disorder, use a wheelchair, and have had impaired sensory function for over a year.You have a pressure injury that touches your seat or had flap surgery in the last six months, difficulty communicating with the study team, or a customized immersion seat cushion.I am a healthcare professional who educates patients on preventing pressure injuries.
Research Study Groups:
This trial has the following groups:- Group 1: Usability-in-home
- Group 2: Usability-inpatients
- Group 3: Focus group-Clinicians
- Group 4: Focus group-Veteran
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Share this study with friends
Copy Link
Messenger